Prikaz osnovnih podataka o dokumentu

dc.creatorMarkelić, M.
dc.creatorBatirel, S.
dc.creatorStančić, Ana
dc.date.accessioned2023-03-03T12:44:04Z
dc.date.available2023-03-03T12:44:04Z
dc.date.issued2023
dc.identifier.issn1664-2392
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fendo.2022.1121518/full
dc.identifier.urihttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC9876656
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/5462
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFrontiers in Endocrinology
dc.subjectbeta cell death
dc.subjectdiabetes
dc.subjectdiabetic complications
dc.subjectferroptosis
dc.subjectislet amyloid polypeptide
dc.titleEditorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting.
dc.typeotheren
dc.rights.licenseBY
dc.rights.holder© 2023 Markelic, Batirel and Stancic.
dc.citation.volume13
dc.identifier.doi10.3389/fendo.2022.1121518
dc.identifier.pmid36714588
dc.identifier.scopus2-s2.0-85146983756
dc.identifier.wos000922355200001
dc.citation.apaMarkelic, M., Batirel, S., & Stancic, A. (2023). Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting. Frontiers in Endocrinology, 13, 1121518.
dc.citation.vancouverMarkelic M, Batirel S, Stancic A. Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting. Front Endocrinol (Lausanne). 2023;13:1121518.
dc.citation.spage1121518
dc.type.versionpublishedVersion
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/12404/fendo-13-1121518.pdf


Dokumenti

Thumbnail

Ovaj dokument se pojavljuje u sledećim kolekcijama

Prikaz osnovnih podataka o dokumentu